CK
Cory Kasimov Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
88.2%
Neutral
11.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $80 |
33%
upside
| 1 | +21% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $12 |
107%
upside
| 1 | +16% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $18 |
29%
upside
| 1 | +40% |
0
%
| 22 Aug ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $34 |
59%
upside
| 2 | +14% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $55 |
39%
upside
| 1 | +34% |
0
%
| 14 May ‘25 5 months ago |
|
|
|
In-Line
Maintained
| $32 |
19%
upside
| 2 | – |
–
| 2 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $185 |
35%
upside
| 1 | +32% |
0
%
| 24 Apr ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $65 |
38%
upside
| 2 | +15% |
0
%
| 12 Feb ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $50 |
10%
downside
| 1 | +109% |
0
%
| 23 Dec ‘24 9 months ago |
|
|
|
Outperform
Maintained
| $50 |
231%
upside
| 2 | -26% |
0
%
| 17 Dec ‘24 9 months ago |
|
|
|
Outperform
Upgraded
| $125 |
22%
upside
| 1 | +0.19% |
0
%
| 19 Nov ‘24 10 months ago |
|
|
|
Outperform
Maintained
| $105 |
101%
upside
| 1 | -25% |
0
%
| 30 Oct ‘24 11 months ago |
|
|
|
Outperform
Maintained
| $1,175 |
108%
upside
| 1 | -40% |
0
%
| 24 Oct ‘24 11 months ago |
|